Adrian Gottschalk Foghorn Therapeutics Inc. (FHTX) insider trading activity

Adrian Gottschalk is Chief Executive Officer of Foghorn Therapeutics Inc.. Currently has a direct ownership of 0 shares of FHTX, which is worth approximately $0. The most recent transaction as insider was on Aug 17, 2023, when has been sold 63,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

ADRIAN GOTTSCHALK Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 17 2023	SELL Bona fide gift	-	63,000 Reduced 100.0%	0 Common Stock
Feb 17 2023	SELL Bona fide gift	-	4,371 Reduced 6.49%	63,000 Common Stock
Oct 25 2022	BUY Other acquisition or disposition	-	4,371 Added 6.09%	67,371 Common Stock
Sep 16 2022	BUY Exercise of conversion of derivative security	$21,600 $0.54 p/Share	40,000 Added 17.66%	186,479 Common Stock
Feb 10 2022	SELL Bona fide gift	-	123,479 Reduced 84.3%	23,000 Common Stock
Aug 20 2021	BUY Exercise of conversion of derivative security	$12,420 $0.54 p/Share	23,000 Added 4.9%	446,479 Common Stock

Adrian Gottschalk

Chief Executive Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FHTX shares.

Notify only if

Value

Insider Trading

Get notified when an Foghorn Therapeutics Inc. insider buys or sells FHTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Foghorn Therapeutics Inc.

Track Activities on FHTX

Account